3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
2
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Tumor-Agnostic
1
Other
1
Conditions
Neoplasms
2
Thyroid Neoplasms
1
Psoriasis Vulgaris
1
Pelvic Neoplasms
1
Mucositis
1
Malnutrition
1
Infections
1
Gastrointestinal Neoplasms
1
Fibrosis
1
Enteritis
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Cancer Therapy-related Cardiovascular Toxicity
1
Anus Neoplasms
1
Adenomatous Polyposis Coli
1
Interventions
Exercise
19
Drug Therapy
18
pembrolizumab
13
Capecitabine
11
Blood Specimen Collection
11
Surveys and Questionnaires
10
Radiotherapy
10
Paclitaxel
9
Dexamethasone
9
Nivolumab
8
Standard of Care
7
Oxaliplatin
7
Fluorouracil
7
Erlotinib Hydrochloride
7
apatinib
6
Interviews as Topic
6
Gemcitabine
6
Control Groups
6
Cisplatin
6
Therapeutics
5
Neoadjuvant Therapy
5
Mindfulness-Based Cognitive Therapy
5
Metformin
5
Injections
5
Everolimus
5
Docetaxel
5
Cyclophosphamide
5
Bevacizumab
5
sintilimab
4
atezolizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasms
×
Probiotics
×
Clear all
NCT03785938
2018-12-24
MaCROS
University of Leeds
Phase NA
Unknown
40 enrolled
NCT01706393
2013-04-19
RTxIMprobio
Seoul National University Hospital
Phase NA
Unknown
26 enrolled